Introduction: Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) have been a major global public health crisis since the 1980s. Although there is still no cure for HIV/AIDS, antiretroviral therapy (ART) has revolutionized the treatment and management of the disease. ART involves the use of a combination of medications…
There are several organizations and entities that are major donors and supporters of HIV research. While this list is by no means complete, some of the largest donors and supporters include: 1. The National Institutes of Health (NIH): The NIH is the primary federal agency responsible for conducting and supporting…
AIDS/HIV was once considered a death sentence, but thanks to advancements in medical research and treatment, people living with the virus can now lead long and healthy lives. According to hiv.org, a diagnosis of AIDS/HIV in the early 1990s was a grim prospect. At that time, there was limited understanding…
Acquired Immune Deficiency Syndrome (AIDS) is an illness caused by HIV. AIDS is the stage of infection that occurs when your immune system is badly damaged and you become vulnerable to opportunistic infections. Without treatment, people who are living with AIDS typically survive about 3 years. There are medications, such…
By Steven Reinberg HealthDay Reporter THURSDAY, May 12 (HealthDay News) — People with HIV can reduce the risk of infecting their sex partners by more than 90 percent if they start treatment with antiretroviral drugs when their immune system is still relatively healthy, researchers announced Thursday. The study, which included…
Stroke rates have increased among people with HIV in recent years while declining in the U.S. population at large, new research shows, raising the possibility that treatments for the AIDS-causing virus may put these patients at higher risk for cardiovascular trouble. There’s no direct proof linking the medications to the…
MONDAY, Oct. 4 (HealthDay News) — One in four people infected with HIV suffer from neurological complications, new Canadian research reveals. And those that do have such problems harbor double the risk of dying compared with HIV patients who are not plagued with neurological diseases, the study authors reported in…
A new study shows that HIV-positive babies with stabilized infections "will do just fine switching to a regime of nevirapine, a reverse transcriptase inhibitor," from a more expensive protease inhibitor, Scientific American's "Observations" blog reports (Harmon, 9/7).
That's the finding of Swedish researchers who analyzed samples from about 70 HIV-infected patients who'd been taking anti-HIV drugs. The tests showed that about 10 percent of the patients -- a larger proportion than expected -- had traces of HIV in their spinal fluid but not in their blood.
Media outlets continued to reflect on news from the International AIDS Conference-AIDS 2010, which attracted over 19,000 participants from 197 countries to Vienna last week, according to the conference blog.
© 2025 Aids.org
